Supernus Pharmaceuticals SUPN Reports Strong Q1 2026 Revenue NA EPS Beats Japans DBJ Explores Extended Investment Horizon to Strengthen Domestic Reshoring Efforts Oil Prices Maintain Elevated Trajectory Amid Persistent Supply Constraints Trumps Approval Rating Drops to 35 as Republican Support Weakens Market Implications